Decentralized Clinical Trials: The patient-centric future of oncology R&D?
Join Labcorp Drug Development and Median Technologies leaders in a stimulating conversation to learn how proven, modern, decentralized clinical trial (DCT) strategies will improve patient compliance and engagement, accelerate timelines, and decrease site burden. Learn how a patient-centric DCT study approach will:
- Expand clinical trial access to a wider more diverse pool of cancer patients
- Increase participant recruitment, engagement, and retention
- Provide a stronger evidence package
- Generate efficient, centralized, and timely data collection
- Leverage technologies to solve study challenges
Full or Hybrid DCT? What is the best fit when it comes to oncology research, the role of clinical trial imaging with these models, and how do you ensure success? Join this webinar to gain insight into DCT strategies and tools to consider for your next oncology trial. If you are a sponsor, CRO, site investigator or a physician, this webinar is for you!
Presenters
- Begoña de las Heras Garcia – Senior Medical Director Oncology at Labcorp
- Clare Campbell – Senior Director, Enterprise DCT and Patient Centric Solutions at Labcorp
- Amani Chassagneux – Project Manager at Median Technologies